Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seungbin Han

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Epigenetics|April 2, 2026
Promoter hypomethylation drives ABCB1-mediated carfilzomib resistance in multiple myelomaSeungbin Han, Larissa Haertle, Umair Munawar, et al.
Cancers|January 21, 2023
Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (<i>PSMC</i>) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple MyelomaLarissa Haertle, Natalia Buenache, Hipólito Nicolás Cuesta Hernández, et al.
Biomarker Research|May 16, 2023
Bortezomib induced peripheral neuropathy and single nucleotide polymorphisms in PKNOX1Xiang Zhou, Seungbin Han, Nadine Cebulla, et al.
Blood|June 11, 2021
Cereblon enhancer methylation and IMiD resistance in multiple myelomaLarissa Haertle, Santiago Barrio, Umair Munawar, et al.
Human Genetics|June 20, 2021
Unraveling the genetic complexities of combined retinal dystrophy and hearing impairmentPaulina Bahena, Narsis Daftarian, Reza Maroofian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2022
Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple MyelomaLarissa Haertle, Santiago Barrio, Umair Munawar, et al.
Leukemia|March 31, 2026
Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapyUmair Munawar, Johanna Thurner, Silvia Nerreter, et al.
Communications Biology|December 22, 2023
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple MyelomaUmair Munawar, Xiang Zhou, Sabrina Prommersberger, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Epigenetics|April 2, 2026
Promoter hypomethylation drives ABCB1-mediated carfilzomib resistance in multiple myelomaSeungbin Han, Larissa Haertle, Umair Munawar, et al.
Cancers|January 21, 2023
Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (<i>PSMC</i>) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple MyelomaLarissa Haertle, Natalia Buenache, Hipólito Nicolás Cuesta Hernández, et al.
Biomarker Research|May 16, 2023
Bortezomib induced peripheral neuropathy and single nucleotide polymorphisms in PKNOX1Xiang Zhou, Seungbin Han, Nadine Cebulla, et al.
Blood|June 11, 2021
Cereblon enhancer methylation and IMiD resistance in multiple myelomaLarissa Haertle, Santiago Barrio, Umair Munawar, et al.
Human Genetics|June 20, 2021
Unraveling the genetic complexities of combined retinal dystrophy and hearing impairmentPaulina Bahena, Narsis Daftarian, Reza Maroofian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2022
Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple MyelomaLarissa Haertle, Santiago Barrio, Umair Munawar, et al.
Leukemia|March 31, 2026
Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapyUmair Munawar, Johanna Thurner, Silvia Nerreter, et al.
Communications Biology|December 22, 2023
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple MyelomaUmair Munawar, Xiang Zhou, Sabrina Prommersberger, et al.
Pageof 2